615 related articles for article (PubMed ID: 24280877)
21. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
[TBL] [Abstract][Full Text] [Related]
22. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Inflamm Bowel Dis; 2020 Mar; 26(4):502-509. PubMed ID: 31613959
[TBL] [Abstract][Full Text] [Related]
23. Medical therapy for induction and maintenance of remission in pouchitis: a systematic review.
Sandborn WJ; McLeod R; Jewell DP
Inflamm Bowel Dis; 1999 Feb; 5(1):33-9. PubMed ID: 10028447
[TBL] [Abstract][Full Text] [Related]
24. Antibiotics and probiotics in treatment of inflammatory bowel disease.
Gionchetti P; Rizzello F; Lammers KM; Morselli C; Sollazzi L; Davies S; Tambasco R; Calabrese C; Campieri M
World J Gastroenterol; 2006 Jun; 12(21):3306-13. PubMed ID: 16733845
[TBL] [Abstract][Full Text] [Related]
25. Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases.
Chapman TM; Plosker GL; Figgitt DP
BioDrugs; 2007; 21(1):61-3. PubMed ID: 17263590
[TBL] [Abstract][Full Text] [Related]
26. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
Ganji-Arjenaki M; Rafieian-Kopaei M
J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
[TBL] [Abstract][Full Text] [Related]
27. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
Bonapace CR; Mays DA
Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
[TBL] [Abstract][Full Text] [Related]
28. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
Seksik P; Dray X; Sokol H; Marteau P
Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
[TBL] [Abstract][Full Text] [Related]
29. Probiotics for induction of remission in ulcerative colitis.
Mallon P; McKay D; Kirk S; Gardiner K
Cochrane Database Syst Rev; 2007 Oct; (4):CD005573. PubMed ID: 17943867
[TBL] [Abstract][Full Text] [Related]
30. Probiotics (VSL#3) in arthralgia in patients with ulcerative colitis and Crohn's disease: a pilot study.
Karimi O; Peña AS; van Bodegraven AA
Drugs Today (Barc); 2005 Jul; 41(7):453-9. PubMed ID: 16193098
[TBL] [Abstract][Full Text] [Related]
31. Probiotics in the management of Crohn's disease and ulcerative colitis.
Müllner K; Miheller P; Herszényi L; Tulassay Z
Curr Pharm Des; 2014; 20(28):4556-60. PubMed ID: 24180407
[TBL] [Abstract][Full Text] [Related]
32. Diet therapy for inflammatory bowel diseases: The established and the new.
Durchschein F; Petritsch W; Hammer HF
World J Gastroenterol; 2016 Feb; 22(7):2179-94. PubMed ID: 26900283
[TBL] [Abstract][Full Text] [Related]
33. High-dose probiotics for the treatment of active pouchitis.
Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
[TBL] [Abstract][Full Text] [Related]
34. Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis.
Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
Gut; 2004 Jan; 53(1):108-14. PubMed ID: 14684584
[TBL] [Abstract][Full Text] [Related]
35. Remission induction and maintenance effect of probiotics on ulcerative colitis: a meta-analysis.
Sang LX; Chang B; Zhang WL; Wu XM; Li XH; Jiang M
World J Gastroenterol; 2010 Apr; 16(15):1908-15. PubMed ID: 20397271
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis.
Gionchetti P; Calabrese C; Lauri A; Rizzello F
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1175-81. PubMed ID: 26202437
[TBL] [Abstract][Full Text] [Related]
37. Probiotics in inflammatory bowel disease: is it fair to lump them into a one size that fits all?
Mardini HE; Grigorian A
Inflamm Bowel Dis; 2014 Jun; 20(6):e14. PubMed ID: 24788040
[No Abstract] [Full Text] [Related]
38. Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review.
Jeong DY; Kim S; Son MJ; Son CY; Kim JY; Kronbichler A; Lee KH; Shin JI
Autoimmun Rev; 2019 May; 18(5):439-454. PubMed ID: 30844556
[TBL] [Abstract][Full Text] [Related]
39. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease.
Yang C; Singh P; Singh H; Le ML; El-Matary W
Aliment Pharmacol Ther; 2015 Jun; 41(11):1079-93. PubMed ID: 25858208
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroid-Free Remission vs Overall Remission in Clinical Trials of Moderate-Severe Ulcerative Colitis and Crohn's Disease.
George J; Singh S; Dulai PS; Ma C; Nguyen T; Feagan BG; Sandborn WJ; Jairath V
Inflamm Bowel Dis; 2020 Mar; 26(4):515-523. PubMed ID: 31504528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
